Navigation Links
Alfacell Provides Shareholder Update
Date:6/19/2009

o conduct a clinical trial in non small cell lung cancer (NSCLC) in patients who have become resistant to platinum therapy. Dr. David Sidransky (Alfacell Chairman of the Board) is spearheading this effort and is in the process of finalizing a special protocol assessment (SPA) which will be presented to the FDA. The patients will be evaluated radiologically for tumor response and will also be evaluated for the time to tumor progression, survival, and side effects of treatment.

Today, other important scientific developments are underway. We are investigating ways to generate revenue from our compounds outside of the clinical and regulatory arena. One such experiment we are looking into is whether Onconase can be used as routine tool to detect the gene silencing via RNA interference (RNAi) mechanism. Currently, there are thousands of researchers interested in finding the answer about the RNAi-mediated gene regulation using their gene of interest. Should we be able to get a positive result, researches from all over the world could be potential buyers of Onconase. We anticipate results shortly.

Other studies will be conducted in order to elucidate if Onconase is able to down regulate the protein produced by the MDR1 gene. There is ample evidence this may be the case, and if so, as previously mentioned, Onconase would be a strong candidate to be used as an adjunct to other chemo therapy regimes.

Of course, our ability to continue with these efforts will depend on our ability to obtain additional financing in the near-term. Talks have been ongoing with potential private investors regarding recapitalizing the company. We cannot assure you, however, that we will be able to secure the necessary financing to maintain the company's operations and pursue these worthwhile projects. It is my sincere hope investors and shareholders alike will see the value in our compounds and continue supporting the company. As I stated earlie
'/>"/>

SOURCE Alfacell Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alfacell Provides ONCONASE(R) NDA Submission Update
2. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
3. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
4. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
5. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
6. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
7. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
9. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... NeuroCall, Inc., ("NeuroCall") announced today that it ... Teleneurology services. Dr. Ricardo Garcia-Rivera , Founder and ... proud that our quality of service has been recognized ... lifesaving support and continuity of care to patients of ... the United States ." NeuroCall ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum Materials ... volume production of photoactive quantum dots for use ... While offering numerous advantages for solar power generation, ... quantities of quantum dots with which to develop ... them from commercial utilization and acceptance. The company ...
(Date:10/1/2014)... Sophia Genetics, leader européen ... l,analyse des données issues du SNG (séquençage nouvelle ... in vitro (IVD) du gène CFTR permettant aux ... dans un seul essai SGN. La solution CE-IVD ... de variantes par l,intermédiaire d,un seul essai SGN, ...
Breaking Medicine Technology:NeuroCall Awarded Joint Commission Accreditation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3
... SADDLE BROOK, N.J., April 27, 2011 Okay, so ... day, but these two working moms are certainly creating ... two high-achieving working moms with formidable educational credentials on ... entrepreneurial detour, something truly unexpected happened...they started selling the ...
... 27, 2011 Wolters Kluwer Health, a leading ... and institutions in medicine, nursing, allied health and pharmacy, ... to acquire Lexi-Comp, Inc., a leading global provider of ... The acquisition is the latest in a series of ...
Cached Medicine Technology:Not Your Average Working Moms 2Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp 2Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp 3Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp 4
(Date:10/1/2014)... 2014 NoteSwift Inc., announced today their ... 12.1 and 13.0. NoteSwift is the bridge between the ... navigate and document clinical information at the point of ... a patient note by more than half – and ... pain points providers state impedes EHR use according to ...
(Date:10/1/2014)... On Sept. 9, Chapín Coffee was selected ... Stewart American Made Awards (MSAMAs), an annual competition in ... the fields of crafts, design, food and style. ... in the MSAMAs, which celebrates entrepreneurs and artisans who ... communities and changing the way we shop, work and ...
(Date:10/1/2014)... Deland, Florida (PRWEB) October 01, 2014 ... to promote awareness and early detection plans while raising ... to support Breast Cancer Awareness Month in ... Water also wants to promote the importance of having ... contaminated drinking water may be linked to certain forms ...
(Date:10/1/2014)... 2014 Today marks the final day ... Institute in Oxnard and Woodland Hills, Calif., is in ... rehabilitation training. , “Speaking to this group of specialists ... to get the help and care they deserve,” Dr. ... previous dental work, providing cosmetic dentistry, correcting bite issues, ...
(Date:10/1/2014)... After undergoing a trial-and-error process in an ... join, Living Well Assisted Living at Home recently joined ... the home of its headquarters. , Although Living Well’s ... thought of adding one more activity to their busy ... the right chamber to join because membership in the ...
Breaking Medicine News(10 mins):Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Living Well Joins San Rafael Chamber of Commerce 2Health News:Living Well Joins San Rafael Chamber of Commerce 3
... encourage health care providers to take into account the number ... tumor cells in colon cancer patients, taken during follow up. ... of reccurence , as this number was shown to ... comeback. ,Lymph node evaluation is important for determining ...
... by addiction specialists and published in Lancet Medical journal, tobacco ... drugs. Prof David Nutt from Bristol University headed this research. ... fifth most dangerous drug followed by ketamine, speed and safety. ... less harmful than tobacco and is recently downgraded to class ...
... in the United States has urged drug companies to print ... treat sleep disorder. FDA has also ordered the companies to ... ,Last week the FDA had underlined the harmful effects of ... incidents of weird behavior like cooking food, eating and even ...
... conducted by Dr. Steriani Elavsky, women passing through their menopause ... they exercised. The improvements in heart and respiratory fitness are ... of life. ,This research was carried out on ... on a random basis. One group was assigned to perform ...
... all private hospitals, built on subsidised government land, must ... indoor and outdoor facilities or face contempt of court ... poor "obligatory" at hospitals built on subsidised land, a ... Malhotra said the hospitals are obliged to provide free ...
... World Health Organisation (WHO) has claimed that the global tuberculosis ... it declared TB a public health emergency in 1993. // ... before the world TB day, says that the percentage ... but has held steady in 2005. ,United Nations ...
Cached Medicine News:Health News:Doctors Warned to Keep Track of Tumorous Lymph Nodes 2Health News:Private Clinics on Public Land Must Treat Poor Free: Court 2Health News:Global Tuberculosis Epidemic Levelling Off - WHO 2
... femoral option and tibial insert which provides a ... degrees of flexion to induce a smooth stable ... of flexion. Femoral component comes in a PS ... constrained tibial insert in conjunction with the femur ...
... True to its leadership role within the ... clinical experience of the industry's leading fixed-bearing ... Knee System, with the clinically proven technology ... leading rotating platform knee. ,The result is ...
... The Femoral component of ... soft tissue and bony destruction ... a high rate of long ... for minimum bone resection and ...
... Knee System is taking total knee replacement to ... of clinical experience. One thing has become clear ... several choices for their patients. Surgeon choice ... factor in long-term patient satisfaction. Biomet responded to ...
Medicine Products: